{'text': 'Sanofi gets US approval for use of Priftin drug in latent TB', 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Mon, 01 Dec 2014 08:00:00 GMT', 'description': 'Sanofi gets US approval for use of Priftin drug in latent TB  Reuters', 'url': 'https://news.google.com/rss/articles/CBMi2wFBVV95cUxOS3NwVUFIS0FzN09JbkV6NzVnbUdjYXU4b0JUdVdrWDQxQ1JUc21rZ04zYl9EcU1GbnBuV3lNNlhpc0tCVm1HR3JDem1NUDZRdHN4bVlvWUpleGc4dTlNNzAtODJhaUJpV0h4MjJvRGpobE5aRkFCbUdqRHFLYUhReXNYVS1FVDQ2dWxPamJhOXJFbDNoQ1NTS2hhQUN6ZXhqeVplUDRWd1pDZ3NaQkMtaHl5THRUaElnQXcxX29ZSmQtVXR3UlYxUWtMTzhxbUFKMXhaUmo2MjUwQ0U?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection', 'publisher': {'href': 'http://www.multivu.com', 'title': 'MultiVu'}, 'created_at': 'Tue, 02 Dec 2014 08:00:00 GMT', 'description': 'Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection  MultiVu', 'url': 'https://news.google.com/rss/articles/CBMinwFBVV95cUxOX29fTWVPcGU2WXU2ekJUdjE3VW5FSUtwelVIbTVHa2NEbzJqNkJwOHc1LXZKNTNxZjhRaloyZXNRN0stck15WU5wYlVJdTZyUjJ0em1BampsUER0RnRDdnVVdGw3S1Q1RkJDeTBucjdGdGhHT1lRX1ZzZ01YX2Q4V3ZUZU1ZU0x4YlczRUM0WTFzNFRpOUplejlOak9rWlk?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Sanofi confirme être en négociation avec Evotec sur Toulouse', 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Tue, 02 Dec 2014 08:00:00 GMT', 'description': 'Sanofi confirme être en négociation avec Evotec sur Toulouse  Reuters', 'url': 'https://news.google.com/rss/articles/CBMiwgFBVV95cUxObkJEVk5HVkZ6bWFMSmxqVThZQi1mSEhyc0NCN2dTOFdNb013R3N0YU5aVGVSLV91aVpXRm9YdEVzcnNfUWJqZXJHUXNUVzhjbnM2OGpZMXRYTG9qaFpUbHV4OXBWOVNxOWIzdHZGcm5lYmJMUWZxem15azVRblR4NVp4T2pSdlRfenpOQ1FzVFBrMTVFY3BSX0psUE54Q19XUkhoaGR3SXdoTWJOY3lESFFBQ2tleXFLSk9nSlpBa1hfQQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Sanofi gets U.S. approval for use of Priftin drug in latent TB', 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Mon, 01 Dec 2014 08:00:00 GMT', 'description': 'Sanofi gets U.S. approval for use of Priftin drug in latent TB  Reuters', 'url': 'https://news.google.com/rss/articles/CBMi2wFBVV95cUxOVUcySmVQd1BING5DeV91eVlIazlwdE45RVNJOVE0dUtrMHlHdXlUMEpNVGhlRV9Oei1VWHRGUjRlM3VMeTR2Mnh0TWw3dWVDZzNuaFN3S2RIVnJfcDM5WDliazZ0bjBrVkc4RWJMQWRtN3ZJckRjS19WTU1yS1dhNENRWTdZanpCaTQ3cldjem03RXhvVGdna242QnktVUNCM2ZxM0hsNFF6Xy1fN19vZkNKbW1zRzZxWU43QVNOdEEzWFRrQnd6aVRURkYyT0xFTHZLcDdodlFlZ1E?oc=5&hl=en-US&gl=US&ceid=US:en'}
